P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
6,213.00
-35 (-0.56%)
BSENSE

Jun 25, 03:02 PM

BSE+NSE Vol: 6.16 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
393.50
270.16
68.66%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
393.50
270.16
68.66%
Raw Material Cost
137.67
74.30
63.37
85.29%
Purchase of Finished goods
34.95
38.10
-3.15
-8.27%
(Increase) / Decrease In Stocks
-10.23
-12.40
2.17
17.50%
Employee Cost
109.89
61.60
48.29
78.39%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
97.70
83.07
85.03%
Total Expenditure (Excl Depreciation)
453.05
259.30
193.75
74.72%
Operating Profit (PBDIT) excl Other Income
210.61
134.20
76.41
56.94%
Other Income
8.98
10.80
-1.82
-16.85%
Operating Profit (PBDIT)
219.59
145.00
74.59
51.44%
Interest
0.24
0.90
-0.66
-73.33%
Exceptional Items
0.00
6.60
-6.60
-100.00%
Gross Profit (PBDT)
219.35
150.70
68.65
45.55%
Depreciation
11.52
5.00
6.52
130.40%
Profit Before Tax
207.83
145.70
62.13
42.64%
Tax
53.11
35.00
18.11
51.74%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
110.70
44.02
39.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
110.70
44.02
39.77%
Equity Capital
16.60
23.00
-6.40
-27.83%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
48.13
45.07
93.64%
Diluted Earnings per share
93.21
48.07
45.14
93.90%
Operating Profit Margin (Excl OI)
31.73%
34.10%
0.00
-2.37%
Gross Profit Margin
33.05%
38.30%
0.00
-5.25%
PAT Margin
23.31%
28.13%
0.00
-4.82%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024